EU Message: This test is not available to persons established in the EU.
Genetic Insights for Everyday Health Optimization
The DNA Signature – Wellness panel provides a comprehensive genomic blueprint of an individual’s foundational vitality, metabolic potential, physical performance, and biological aging trajectory.
By evaluating interconnected pathways governing cellular energy (Mitochondrial Function, Oxidative Stress, Telomere Length), macronutrient response (Glucose Metabolism, Protein Benefit), and physical resilience (Muscle Mass, Soft Tissue & Cartilage Risk, Recovery Speed), this panel pinpoints an individual’s unique physiological capacity. It translates complex genetic data into targeted dietary, exercise, and lifestyle interventions. Helping practitioners design proactive protocols to optimize athletic performance, prevent soft-tissue injury, and promote long-term vitality.
What Patients Might Benefit from DNA Signature – Wellness Testing?
Patients with the following symptoms or conditions may benefit from DNA Signature – Wellness testing
Athletes & Active Individuals Seeking Performance Optimization
Seeking Metabolic & Weight Optimization
Focused on Healthy Aging & Longevity
Struggling with Sleep, Fatigue, or Slow Exercise Recovery
Details
Why Use the DNA Signature – Wellness Profile?
The DNA Signature – Wellness Profile provides a comprehensive genomic blueprint of an individual’s foundational vitality, physical performance potential, metabolic efficiency, and long-term biological aging trajectory. By evaluating interconnected pathways across cellular energetics, musculoskeletal resilience, and lifestyle behaviors, this panel helps practitioners go beyond basic fitness or diet advice to design highly targeted, preventative lifestyle protocols.
Core Functional Domains Evaluated
Cellular Health, Aging & Longevity
Longevity & Biological Age: Assesses genetic propensity for longevity, telomere length maintenance, and structural APOE status to map baseline cellular aging and cardiovascular/neuro-metabolic resilience
Mitochondrial Output & Defense: Evaluates mitochondrial function, oxidative stress buffering capacity, and nitric oxide regulation for vascular flow and cellular oxygenation.
Metabolic & Dietary Response Profiles
Glycemic & Energy Efficiency: Maps glucose metabolism and complex carbohydrate utilization to optimize dietary macronutrient ratios.
Protein Dynamics & Micronutrients: Assesses individual protein benefit for lean tissue maintenance and identifies genetic risks in vitamin D3 conversion efficiency.
Physical Performance, Recovery & Tissue Integrity
Musculoskeletal Potential: Evaluates genetic capacity for muscle mass development and intrinsic exercise motivation.
Soft Tissue & Joint Resilience: Maps structural risk profiles for soft tissue and cartilage injury risk inform injury prevention strategies.
Recovery Dynamics: Measures baseline recovery speed post-exertion to optimize training volume and rest intervals.
Neuro-Systemic Adaptation & Sleep
Systemic Stress Handling: Assesses biological stress adaptation capacity to prevent burnout and overtraining.
Restorative Rest
Evaluates genetic predispositions influencing reported sleep quality and circadian recovery.
Our high-complexity laboratory is committed to delivering accurate and reliable results in coordination with these top licensure programs:
Analytes
From a single easy-to-collect buccal swab you will receive a personalized polygenic risk score for the following traits:
Longevity Propensity
Mitochondrial Function
Telomere Length
APOE Status
Oxidative Stress
Nitric Oxid Regulation
Glucose Metabolism
Complex Carbohydrate Utilization
Protein Benefit
Vitamin D3 Risk / Conversion
Exercise Motivation
Muscle Mass
Recovery Speed
Soft Tissue Risk
Cartilage Risk
Stress Adaptation
Reported Sleep Quality
Sample Reports
The DNA Methylation Profile report aids clinical support for patients by pinpointing SNPs that could potentially impact health and disease risk.
MosaicDX offers patient-friendly sample collection kits that simplify testing. Our kits include visual, step-by-step instructions for test preparation and sample collection, personalized shipping cards, and pediatric collection bags if needed. With MosaicDX, patients can easily collect samples for testing with confidence and accuracy.
No, we do not. A genetic carrier refers to an individual who has inherited a recessive allele that has been shown to be responsible for an autosomal recessive disease or trait. A genetic carrier only has one recessive allele so while they do not show signs or symptoms of the trait or disease, they are able to pass along the recessive gene to their child. Our genetic testing is for screening purposes only to assess risk or predisposition for certain traits associated with health and wellness.
No. We do not use patient samples for further research or testing. We may use your de-identified and anonymized data to help improve our algorithm and reports. Your data will not be sold or shared to or with any 3rd parties/commercial interests.
Yes, we can delete the patient’s raw genetic sequence at any time. Please note that applicable federal and state laws require us to retain your patient report and the subset of your data that was used to generate that report for a specified period of time. We will be happy to delete any and all of your data that we are legally allowed to delete upon request. Please submit your request here.
We implement rigorous selection criteria when choosing which genes or SNPs to include in our panels. The selection and validation criteria are based upon peer-reviewed studies that show a significant association between the SNP variant and trait or condition, the magnitude of the odds ratio (OR) or hazard ratio (HR) to assess risk related to the variant, as well as the population or populations the gene and SNP variant were studied in, the population size, and replication of findings.
A genotype refers to the actual inherited genetic material of an individual that can influence or determine certain characteristics or traits. A phenotype is how the genotype is actually expressed, that is the observable or measurable characteristics or traits of an individual.
SNP is also called a Single Nucleotide Polymorphism. Your DNA consists of 4 main building blocks (nucleotides), Adenine (A), Thymine (T), Guanine (G), and Cytosine (C). In certain locations within your DNA, one person may have an A, whereas another may have a G. This difference in the base pair is often called a variant. This variant is an SNP.
In most situations, you do not have to resubmit a DNA buccal swab sample if you later want to order additional panels. The only time a new DNA buccal swab would need to be resubmitted is if the assay has had significant changes, or the patient previously requested that their DNA sequencing results be deleted.
Patients are sent a DNA Signature Collection Kit containing instructions, 1 cheek swab, a DNA Sample Envelope and a prepaid return envelope and biohazard zip-lock bag. Instructions can also be found on our website on the DNA Signature Profiles web page, along with an easy-to-follow video.
A person’s polygenic risk score is a statistical calculation based on the presence or absence of multiple genomic variants without taking environmental or other factors into account
Different states have regulations that define the scope of practice for practitioners. It is the practitioner’s responsibility to abide by these rules. Check with your state board of health to determine any restrictions related to laboratory testing. Please note, Mosaic Diagnostics does not offer testing in New York.
Once you have opened your account, you have the options of ordering kits to stock in your office or drop-ship kits directly to your patients through your MosaicDX portal.
Watch our short tutorial videos on how to conveniently
Bao JM et al. Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis. Asian J Androl. 2014;16(3):446-52. doi:10.4103/1008-682X.123678.
Willcox BJ et al. FOXO3A genotype is strongly associated with human longevity. PNAS. 2008;105(37):13987-92. doi:10.1073/pnas.0801030105. PMID: 18765803.
Willcox BJ et al. FoxO3 gene and cause-specific mortality in the Hawaii Lifespan Study. Aging Cell. 2016;15(4):617-24. doi:10.1111/acel.12479. PMID: 27071935.
Figarska SM, Vonk JM, Boezen HM. SIRT1 polymorphism, long-term survival and glucose tolerance in the general population. PLoS ONE. 2013;8(3):e58636. doi:10.1371/journal.pone.0058636. PMID: 23505545.
TReLong Study. Modulation of human longevity by SIRT3 single nucleotide polymorphisms in the prospective TRELONG study. Age (Dordr). 2013;35(5):1987-98. PMID: 23839864.
Tennapel MJ et al. SIRT6 minor allele genotype is associated with >5-year decrease in lifespan in an aged cohort. PLoS ONE. 2014;9(12):e111335. doi:10.1371/journal.pone.0111335. PMID: 24558382.
Kuo CL, Pilling LC, Kuchel GA, Ferrucci L, Melzer D. Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants. Aging Cell. 2019;18(6):e13017. doi:10.1111/acel.13017.
Soerensen M et al. Genetic variation in TERT and TERC and human leukocyte telomere length and longevity. Aging Cell. 2012;11(2):223-32. doi:10.1111/j.1474-9726.2011.00775.x. PMID: 22092449.
Broer L et al. GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. J Gerontol A Biol Sci Med Sci. 2015;70(1):110-8. doi:10.1093/gerona/glu166.
Deelen J et al. A meta-analysis of genome-wide association studies identifies multiple longevity genes. Nat Commun. 2019;10(1):3669. doi:10.1038/s41467-019-11558-2.
Sebastiani P et al. Genetic signatures of exceptional longevity in humans. PLoS ONE. 2017;12(2):e0169459. PMID: 30060062.
Jung IE, da Cruz IBM, Barbisan F et al. Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases risk of depression and psychological stress in free-living elderly. Mol Genet Genomic Med. 2019;8(2):e1080. doi:10.1002/mgg3.1080.
Hernando B et al. The effect of long-term ultra-endurance exercise and SOD2 genotype on telomere shortening with age. J Appl Physiol. 2021;130(1):48-57. doi:10.1152/japplphysiol.00555.2020. PMID: 32881625.
Zhu Z et al. Klotho gene polymorphisms are associated with healthy aging and longevity: Evidence from a meta-analysis. Mech Ageing Dev. 2019;178:33-40. doi:10.1016/j.mad.2018.12.003. PMID: 30633899.
Di Bona D et al. Association of Klotho polymorphisms with healthy aging: a systematic review and meta-analysis. Rejuvenation Res. 2014;17(2):212-6. doi:10.1089/rej.2013.1523. PMID: 24164579.
Di Bona D et al. Insulin-like growth factor 1 receptor (IGF1R) polymorphism and human longevity. Curr Vasc Pharmacol. 2014;12(5):674-9. doi:10.2174/1570161111666131218152807.
Kolovou GD et al. The frequency of 4 common gene polymorphisms in nonagenarians, centenarians, and average life span individuals. Angiology. 2014;65(3):210-5. doi:10.1177/0003319712475075. PMID: 23389097.
Sarhangi N et al. PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis. Sci Rep. 2020;10(1):12764. doi:10.1038/s41598-020-69543-5. PMID: 32728045.
Moazzam-Jazi M et al. Risk of type 2 diabetes and KCNJ11 gene polymorphisms: a nested case-control study and meta-analysis. Sci Rep. 2022;12(1):20943. doi:10.1038/s41598-022-25447-4. PMID: 36456687.
Prokopenko I et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009;41(1):77-81. doi:10.1038/ng.290. PMID: 19324940.
Li H et al. Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis. Mol Biol Rep. 2013;40(7):4247-56. doi:10.1007/s11033-013-2506-7. PMID: 23307301.
Qi Q et al. Insulin receptor substrate 1 (IRS1) gene variation modifies insulin resistance response to weight-loss diets: a two-year randomized trial. Circulation. 2011;124(5):563-71. doi:10.1161/CIRCULATIONAHA.111.025767. PMID: 21747052.
Merritt DC et al. FTO genotype, dietary protein intake, and body weight in a multiethnic population of young adults. Genes Nutr. 2018;13:4. doi:10.1186/s12263-018-0593-7.
Stocks T et al. TFAP2B — dietary protein and glycemic index interactions and weight maintenance after weight loss in the DiOGenes trial. Hum Hered. 2013;75(2-4):213-9. doi:10.1159/000353591. PMID: 24081236. composition and energy metabolism response to energy restriction in obese women. Br J Nutr. 2011;106(4):486-90. doi:10.1017/S0007114511000432. PMID: 21392418.
Ochoa MC et al. Association between obesity and insulin resistance with UCP2-UCP3 gene variants in Spanish children and adolescents. Mol Genet Metab. 2007;92(4):351-8. doi:10.1016/j.ymgme.2007.07.011. PMID: 17870627.
Bulgay C et al. The AMPD1 Gene’s rs17602729 Polymorphism and Athletic Performance in Track and Field Athletes. Appl Sci. 2024;14(2):891. doi:10.3390/app14020891.
Semenova EA, Hall ECR, Ahmetov II. Genes and Athletic Performance: The 2023 Update. Genes (Basel). 2023;14(6):1235. doi:10.3390/genes14061235. PMID: 37372415.
Baumert P et al. Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing. Eur J Appl Physiol. 2016;116(9):1595-625. doi:10.1007/s00421-016-3411-1. PMID: 27294501.
Sprouse C et al. SLC30A8 nonsynonymous variant is associated with recovery following exercise and skeletal muscle size and strength. Diabetes. 2014;63(1):363-8. doi:10.2337/db13-1150. PMID: 24101675.
Martinez Serrano J et al. The influence of Val158Met COMT on physiological stress responsivity. Stress. 2019;22(2):276-279. doi:10.1080/10253890.2018.1548540.
Lovallo WR et al. Joint impact of early life adversity and COMT Val158Met (rs4680) genotypes on the adult cortisol response to psychological stress. Psychosom Med. 2017;79(7):820-828. doi:10.1097/PSY.0000000000000483. PMID: 28525432.
Gerstner JR et al. Normal sleep requires the astrocyte brain-type fatty acid binding protein FABP7. Sci Adv. 2017;3(4):e1602663. doi:10.1126/sciadv.1602663. PMID: 28435883.
Li YL et al. Association between the CLOCK gene polymorphism and depressive symptoms mediated by sleep quality. J Affect Disord. 2021;281:631-638. doi:10.1016/j.jad.2020.11.094. PMID: 32633440.
Kripke DF et al. Genetic variants associated with sleep disorders. Sleep Med. 2015;16(2):217-24. doi:10.1016/j.sleep.2014.11.003. PMID: 25660813.
Moore H et al. Periodic limb movements during sleep are associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRD. Sleep. 2014;37(9):1535-42. doi:10.5665/sleep.4006. PMID: 25142570.
Winkelmann J et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007;39(8):1000-6. doi:10.1038/ng2099. PMID: 17637780.
Bachmann V et al. The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep. 2012;35(3):335-44. doi:10.5665/sleep.1690.
Tartar JL et al. A functional adenosine deaminase polymorphism associates with evening melatonin levels and sleep quality. J Circadian Rhythms. 2021;19:5. doi:10.5334/jcr.209. PMID: 33981350.
